A Disease Mapping for Elithia

Abstract

There are plenty of medical conditions, each of them with its own unmet medical needs. NLC is a health-tech venture builder that aims to tackle these unmet medical needs by building startups. NLC builds startups through entrepreneurship at scale, i.e., seizing all the knowledge gathered in developing these ventures and standardizing the process of building them up so that it happens faster and more efficiently. NLC provides funding to its ventures through its funds. The newest fund, Elithia, is focused on bringing the next generation of impactful biotech ventures in the fields of neurobiology and immunology. However, the unmet medical needs of these conditions remain unknown to the Elithia team. In consequence, in this thesis report, I have reviewed 39 neurobiological and immunological conditions and shed light on the current diagnostic and therapeutic gaps. To this end, I have collected the data in fact sheets – this way, the data, and findings are more accessible to the Elithia team. Following this review, I could observe the high variability regarding unmet medical needs between all these conditions. Yet, the diagnostic needs have stood out. Molecular or digital biomarkers would be of much help in diagnosing a wide array of conditions such as bipolar disorder or systemic lupus erythematosus and help the patient receive adequate treatment early on.